Page last updated: 2024-11-13

latilagascene f

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

latilagascene F: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID44588922
CHEMBL ID519354
MeSH IDM0506714

Synonyms (2)

Synonym
CHEMBL519354
latilagascene f
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID1377026Cytotoxicity against human KB cells assessed as growth inhibition after 72 hrs by MTT assay2017Journal of natural products, 06-23, Volume: 80, Issue:6
Terpenoids from Euphorbia soongarica and Their Multidrug Resistance Reversal Activity.
AID471323Cytotoxicity against human A2780 cells after 4 days by MTT assay2009Journal of natural products, Sep, Volume: 72, Issue:9
Chemical Constituents of the Roots of Euphorbia micractina.
AID471325Antiviral activity against HIV-1 NL4-3 expressing VSV-G envelope infected in human 293T cells assessed as inhibition of viral replication after 48 hrs by Luciferase reporter gene assay2009Journal of natural products, Sep, Volume: 72, Issue:9
Chemical Constituents of the Roots of Euphorbia micractina.
AID1377027Cytotoxicity against human KBv200 cells assessed as growth inhibition after 72 hrs by MTT assay2017Journal of natural products, 06-23, Volume: 80, Issue:6
Terpenoids from Euphorbia soongarica and Their Multidrug Resistance Reversal Activity.
AID1377028Inhibition of P-gp in human KBv200 cells assessed as increase in intracellular rhodamine123 accumulation by measuring fluorescence activity ratio at 10 uM incubated for 4 hrs followed by rhodamine123 addition measured after 1 hr by flow cytometry2017Journal of natural products, 06-23, Volume: 80, Issue:6
Terpenoids from Euphorbia soongarica and Their Multidrug Resistance Reversal Activity.
AID471324Inhibition of GST-tagged human PTP1B2009Journal of natural products, Sep, Volume: 72, Issue:9
Chemical Constituents of the Roots of Euphorbia micractina.
AID389396Lipophilicity, log P of the compound2008Bioorganic & medicinal chemistry, Oct-15, Volume: 16, Issue:20
Synergistic interaction between p-glycoprotein modulators and epirubicine on resistant cancer cells.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.56 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]